SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (22065)6/11/1998 8:00:00 AM
From: Mudcat  Read Replies (1) | Respond to of 32384
 
Found some info on insider trades for Lgnd:

biz.yahoo.com

Not much buying just exercising options and no selling.



To: Henry Niman who wrote (22065)6/11/1998 9:08:00 AM
From: Machaon  Read Replies (7) | Respond to of 32384
 
<< Bob, LGND has indicated that small trials on basal and squamous cell carcinoma will be initiated with topical Panretin to allow for off label use. >>

Henry, I looked thru your LGND website, for more info on this, but failed to find an article. Where can I found out more about Ligand's "off label" intentions for Panretin gel?

Thanks, Bob


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News